Axon Enterprise Stock Surges After Strong Q3 Performance

Axon Enterprise stock (NASDAQ: AXON), recognized for its law enforcement products like tasers and body cameras, jumped nearly 30% on Friday, November 8. This surge followed the company’s impressive third-quarter results and an improved financial outlook. Axon reported revenue of $544 million and earnings of $1.45 per share, exceeding analysts’ expectations of $527 million in revenue and $1.20 in earnings per share. The growth reflects a strong adoption of its innovative products.

Product Innovation Driving Growth

Axon has been actively pushing the boundaries of technology with products like Draft One, which utilizes generative AI to turn body camera audio into written reports. The software can even translate over 100 languages, enhancing police efficiency. In Q3, Taser sales soared by 36% year-over-year, totaling $221.7 million, with Cloud & Services also rising by 36% and revenue from Sensors & Other increasing by 18%. Overall, company sales surged by 32%, propelled by strong demand for both tasers and body cameras. Significant revenue increases contributed to an adjusted EBITDA margin expansion of 400 basis points year-over-year, reaching 26.7%. Consequently, earnings per share improved from $1.05 in the previous year to $1.45.

AXON Stock: A Strong Performance in 2023

The year 2023 has proven to be remarkable for AXON stock, boasting an impressive 133% return compared to the S&P 500’s 25%. This trend of outperformance has characterized AXON stock over the last three years, with annual gains of 28% in 2021, 6% in 2022, and 56% in 2023. Likewise, the Trefis High Quality (HQ) Portfolio—a selection of 30 less volatile stocks—has outperformed the S&P 500 annually, demonstrating more favorable risk-adjusted returns.

Future Outlook Amid Economic Uncertainty

As the macroeconomic landscape remains uncertain amidst rate cuts and potential changes from a new Trump presidency, analysts are speculating about further growth for AXON. From a valuation standpoint, the stock appears fully valued at approximately $600, trading at 25x trailing revenues, significantly higher than its average price-to-sales (P/S) ratio of 12x over the past five years. While some adjustment in the valuation multiple seems warranted due to strong sales and earnings growth, cautious investors note that the stock’s valuation has doubled compared to historical averages, raising questions about its long-term affordability.

Comparative Insights

Despite AXON stock appearing fully valued, investors might find it beneficial to review comparisons with other industry players through Peer Comparisons. Additionally, there are notable developments concerning Delta stock.

[1] Returns as of 11/11/2024
[2] Cumulative total returns since the end of 2016

Invest with Trefis Market-Beating Portfolios
See all Trefis Price Estimates

The views and opinions expressed herein are those of the author and do not necessarily reflect the views of Nasdaq, Inc.